Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept

被引:28
作者
Cortot, AB
Cottin, V [1 ]
Miossec, P
Fauchon, E
Thivolet-Béjui, F
Cordier, JF
机构
[1] Univ Lyon 1, Hop Cardiovasc & Pneumol, Serv Pneumol, Ctr Malad Orphelines Pulm,UMR 754, F-69677 Lyon, France
[2] Hop Edouard Herriot, Serv Rhumatol, Unite Immunol Clin, F-69008 Lyon, France
[3] Univ Lyon 1, Hop Cardiovasc & Pneumol Louis Pradel, Serv Cytol & Anat Pathol, F-69677 Lyon, France
关键词
constrictive bronchiolitis; etanercept; rheumatoid arthritis; tumor necrosis factor-alpha;
D O I
10.1016/j.rmed.2004.09.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA)-associated constrictive bronchiolitis is a severe condition with no established efficient treatment. A 55-year-old woman with seropositive RA developed rapidly progressive constrictive bronchiolitis confirmed by lung biopsy. Her clinical condition worsened despite steroids and azathioprine. Treatment with etanercept-a tumor necrosis factor (TNF)-alpha inhibitor-combined with methotrexate, resulted in a marked improvement of both her clinical condition and pulmonary function tests. Treatment with TNF-alpha inhibitors and methotrexate may be proposed in RA-associated constrictive bronchiolitis, a severe condition hitherto not amenable to improvement. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:511 / 514
页数:4
相关论文
共 10 条
[1]   Tumor necrosis factor-α in a porcine bronchial model of obliterative bronchiolitis [J].
Alho, HS ;
Maasilta, PK ;
Harjula, ALJ ;
Hämmäinen, P ;
Salminen, J ;
Salminen, US .
TRANSPLANTATION, 2003, 76 (03) :516-523
[2]   Growth factor upregulation during obliterative bronchiolitis in the mouse model [J].
Aris, RM ;
Walsh, S ;
Chalermskulrat, W ;
Hathwar, V ;
Neuringer, IP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (03) :417-422
[3]   The treatment of interstitial lung disease associated with rheumatoid arthritis with infliximab [J].
Dellaripa, PF ;
Fry, TA ;
Willoughby, J ;
Arndt, WF ;
Angelakis, EJ ;
Campagna, AC .
CHEST, 2003, 124 (04) :109S-109S
[4]  
GEDDES DM, 1977, Q J MED, V46, P427
[5]   Effectiveness of TNF-α blockade with infliximab in refractory Wegener's granulomatosis [J].
Lamprecht, P ;
Voswinkel, J ;
Lilienthal, T ;
Nolle, B ;
Heller, M ;
Gross, WL ;
Gause, A .
RHEUMATOLOGY, 2002, 41 (11) :1303-1307
[6]   Refractory sarcoidosis responding to infliximab [J].
Roberts, SD ;
Wilkes, DS ;
Burgett, RA ;
Knox, KS .
CHEST, 2003, 124 (05) :2028-2031
[7]   Prevention of obliterative airway disease in HLA-A2-transgenic tracheal allografts by neutralization of tumor necrosis factor [J].
Smith, CR ;
Jaramillo, A ;
Lu, KC ;
Higuchi, T ;
Kaleem, Z ;
Mohanakumar, T .
TRANSPLANTATION, 2001, 72 (09) :1512-1518
[8]  
Vassallo Robert, 2002, Chest, V122, P1093, DOI 10.1378/chest.122.3.1093
[9]   A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate [J].
Weinblatt, ME ;
Kremer, JM ;
Bankhurst, AD ;
Bulpitt, KJ ;
Fleischmann, RM ;
Fox, RI ;
Jackson, CG ;
Lange, M ;
Burge, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) :253-259
[10]  
WELLS AU, 1993, CLIN CHEST MED, V14, P655